Company intelligence / Profile preview

Lagoom

Ownership: Private
Development stage: Commercial

Overview

Lagom Life Sciences manufactures precision-engineered fast-dissolving oral strips designed for rapid absorption and accurate dosing of nutrients or drugs. Their products target improved convenience and compliance compared to traditional pills or powders. No clinical trial results are referenced; the focus is on product format innovation rather than new active ingredients.

Therapeutic areas: Other
Modalities: Oral strip delivery technology
Industry: Consumable Medical Devices

Beyond the preview

Go deeper on Lagoom.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lagoom.

Explore the full profile